Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access

Area of Science:

• Nephrology
• Vascular Surgery
• Clinical Trials

Background:

• Arteriovenous access is crucial for hemodialysis.
• Current clinical trials for vascular access lack standardized endpoints.
• The American Society of Nephrology Kidney Health Initiative aims to improve research in this area.

Purpose of the Study:

• To define distinct phases of the arteriovenous access life cycle.
• To identify and clarify appropriate clinical trial endpoints for each phase.
• To inform clinical, regulatory, and coverage decisions for dialysis vascular access.

Main Methods:

• The project divided the arteriovenous access life cycle into five distinct phases.
• Each phase was characterized by objective criteria.
• Clinical trial endpoints were identified for each phase.

Main Results:

• Phase 1: Patent arteriovenous access.
• Phase 2: Physiologically mature arteriovenous access.
• Phase 3: Clinically functional arteriovenous access.
• Phase 4: Sustained clinical use.
• Phase 5: Dysfunction, requiring maintenance.

Conclusions:

• Defined life cycle phases and endpoints will enhance clinical trial design for arteriovenous access.
• Standardized endpoints will provide better data for decision-making.
• This framework supports research and improves patient care in dialysis vascular access.